The off-the-shelf chimeric antigen receptor T-cell therapy P-BCMA-ALLO1 was shown to be safe and elicited strong anti-tumor ...
Monday morning, the rotunda was filled with giggles and chatter as the young persimmon promoters entered the capitol.